Trial: 201911163

Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)

Phase

III

Principal Investigator

Stockerl-Goldstein, Keith

Disease Site

Multiple Myeloma

Learn more about this study at: clinicaltrials.gov